Abstract
Cardiovascular disease is one of the most common causes of mortality affecting both men and women in industrialized nations. Sex-related differences have been well established with regard to heart and vascular function as well as cardiovascular disease processes. Nevertheless, the precise mechanisms of action behind these gender-related differences are poorly understood. Premenopausal women have a relatively lower arterial blood pressure compared to age-matched men and post-menopausal women, suggesting a role of ovarian hormones in blood pressure regulation. Sex-related differences in vasculature and neuroendocrine systems are also present that can affect hemostasis, vascular reactivity, and vascular tone. Treatment for cardiovascular disease and hypertension has been challenging and unsatisfactory. Men and women may require different antihypertensive regimens due to differences in the progression and presentation of hypertension. Additionally, hormone replacement therapy in postmenopausal women has been controversial, producing both beneficial and detrimental effects. Therefore, this review will focus on sex-related differences in the heart and vasculature, and treatments for cardiovascular disease, such as hypertension.
Similar content being viewed by others
References
Accessed Aug. 2005. National Center for Health Statistics and Mortality Data from the National Vital Statistics System @ Centers for Disease Control Website, www.cdc.gov/nchs/deaths.htm.
Accessed Aug. 2005. Hearth Disease and Stroke Statistics @ American Heart Association Website, www.americanheart.org.
Jemal, A., Murray, T., Ward, E., et al. (2005). CA Cancer J. Clin. 55, 10–30.
Schwartzbauer, G. and Robbins, J. (2001). Circulation 104, 1333–1335.
Leinwand, L. A. (2003). J. Clin. Invest. 112, 302–307.
Orshal, J. M. and Khalil, R. A. (2004). Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R233-R249.
Safar, M. E. and Smulyan, H. (2004). Am. J. Hypertens. 17, 82–87.
Janz, K. F., Dawson, J. D., and Mahoney, L. T. (2000). Pediatrics 105, E63.
Forman, D. E., Cittadini, A., Azhar, G., Douglas, P. S., and Wei, J. Y. (1997). J. Am. Coll. Cardiol. 30, 1872–1877.
Hayward, C. S., Webb, C. M., and Collins, P. (2001). Lancet 357, 1354–1356.
Kostkiewicz, M., Tracz, W., Olszowska, M., Podolec, P., and Drop, D. (1999). Int. J. Cardiol. 71, 57–61.
Wallen, W. J., Cserti, C., Belanger, M. P., and Wittnich, C. (2000). Hypertension 36, 774–779.
Lorell, B. H. and Carabello, B. A. (2000). Circulation 102, 470–479.
Thrainsdottir, I. S., Hardarson, T., Thorgeirsson, G., Sigvaldason, H., and Sigfusson, N. (2003). J. Int. Med. 253, 418–424.
Douglas, P. S., Katz, S. E., Weinberg, E. O., Chen, M. H., Bishop, S. P., and Lorell, B. H. (1998). J. Am. Coll. Cardiol. 32, 1118–1125.
Weinberg, E. O., Thienelt, C. D., Katz, S. E., et al. (1999). J. Am. Coll. Cardiol. 34, 264–273.
Simoncini, T., Hafezl-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, J. K. (2000). Nature 407, 538–541.
Ho, K. J. and Liao, J. K. (2002). Mol. Interv. 2, 219–228.
Gerdts, E., Zabalgoitia, M., Bjornstad, H., Svendsen, T. L., and Devereux, R. B. (2001). Am. J. Cardiol. 87, 980–983.
Opie, L. H. (2004). In: Heart physiology: from cell to circulation. Weinberg, R. W., Bersin, J., and Aversa, F. (eds.). Lippincott Williams & Wilkins: Philadelphia, PA, pp. 485–522.
Rosen, B. D., Edvardsen, T., Lai, S., et al. (2005). Circulation 112, 984–991.
Massie, B. M. and Fabi, M. R. (2005). Prog. Cardiovasc. Dis. 47, 389–395.
Stromberg, A. and Martensson, J. (2003). Eur. J. Cardiovasc. Nurs. 2, 7–18.
Reckelhoff, J. F. (2001). Hypertension 37, 1199–1208.
Lockyer, L. (2005). Eur. J. Cardiovasc. Nurs. 4, 29–35.
Chen, W., Woods, S. L., and Puntillo, K. A. (2005). Heart Lung 34, 240–247.
Granot, M., Goldstein-Ferber, S., and Azzam, Z. S. (2004). J. Pain Symptom Manage. 27, 149–155.
Schwertz, D. W. and Penckofer, S. (2001). Heart Lung 30, 401–426.
Esposito, K., Nappo, F., Giugliano, F., Guigliano, G., Marfella, R., and Giugliano, D. (2003). Am. J. Clin. Nutr. 77, 139–143.
Ajayi, A. A., Mathur, R., and Halushka, P. V. (1995). Circulation 91, 2742–2747.
Lawrence, J. B., Leifer, D. W., Moura, G. L., et al. (1995). Am. J. Med. Sci. 309, 201–207.
Mikkola, T., Turunen, P., Avela, K., Orpana, A., Viinikka, L., and Ylikorkala, O. (1995). J. Clin. Endocrinol. Metabol. 80, 2457–2457.
Rossi, R., Grimaldi, T., Origliani, G., Fantini, G., Coppi, F., and Modena, M. G. (2002). Pathophysiol. Haemost. Thromb. 32, 325–328.
Li, Z. and Duckles, S. P. (1994). J. Pharmacol. Exp. Ther. 268, 1426–1431.
Li, Z., Krause, D. N., Doolen, S., and Duckles, S. P. (1997). Am. J. Physiol. 41, H1819-H1825.
Pinto, S., Coppo, M., Paniccia, R., et al. (1990). Prostaglandins Leukot. Essent. Fatty Acids 40, 217–221.
Polderman, K. H., Stehouwer, C. D. A., Vankamp, G. J., et al. (1993). Ann. Intern. Med. 118, 429–432.
Sessa, W. C. (2005). Mem. Inst. Oswaldo Cruz 100, 15–18.
Forte, P., Kneale, B. J., Milne, E., et al. (1998). Hypertension 32, 730–734.
CaulinGlaser, T., GarciaCardena, G., Sarrel, P., Sessa, W. C., and Bender, J. R. (1997). Circ. Res. 81, 885–892.
Radin, M. J., Holycross, B. J., Sharkey, L. C., Shiry, L., and McCune, S. A. (2002). J. Appl. Physiol. 92, 935–940.
Doursout, M. F., Chelly, J. E., Wouters, P., Lawrence, C., Liang, Y. Y., and Buckley, J. P. (1990). Hypertension 15, 1117–1120.
Chen, M. H. and Printz, M. P. (1983). Endocrinology 113, 1503–1510.
Jonklaas, J. and Buggy, J. (1985). Brain Res. 326, 239–249.
Khaw, K. T. and Barrettconnor, E. (1988). J. Hypertension 6, 329–332.
Reckelhoff, J. F., Zhang, H. M., Srivastava, K., Roberts, L. J., Morrow, J. D., and Romero, J. C. (2000). Hypertension 35, 476–479.
Berry, K. L., Cameron, J. D., Dart, A. M., et al. (2004). J. Am. Geriatr. Soc. 52, 368–373.
Wenger, N. K. (2004). J. Am. Coll. Cardiol. 44, 586–587.
Raitakari, M., Ilvonen, T., Ahotupa, M., et al. (2004). Arterioscler. Thromb. Vasc. Biol. 24, 124–128.
Adams, V., Linke, A., Krankel, N., et al. (2005). Circulation 111, 555–562.
Clarkson, T. B. and Appt, S. E. (2003). Steroids 68, 941–951.
Babiker, F. A., De Windt, L. J., van Eickels, M., et al. (2004). Circulation 109, 269–276.
Miya, Y., Sumino, H., Ichikawa, S., et al. (2002). Hypertens. Res. 25, 153–159.
Modena, M. G., Muia, N. J., Aveta, P., Molinari, R., and Rossi, R. (1999). Hypertension 34, 1041–1046.
Sharkey, L. C., Holycross, B. J., Park, S., et al. (1999). J. Mol. Cell Cardiol. 31, 1527–1537.
Sumino, H., Ichikawa, S., Sawada, Y., et al. (2005). Thromb. Res. 115, 359–366.
Wehrmacher, W. H. and Messmore, H. (2005). Gender Med. 2, 4–6.
Nevala, R., Vaskonen, T., Vehniainen, J., Korpela, R., and Vapaatalo, H. (2000). Life Sci. 66, 115–124.
Jin, Z. M. and MacDonald, R. S. (2002). J. Nutr. 132, 3186–3190.
Ruilope, L. M. and Suarez, C. (1997). Am. J. Hypertens. 10, 242S-246S.
Guyton, A. C. and Hall, J. E. (1995). Textbook of medical physiology (9th edn), WB Saunders/Elsevier Inc., Philadelphia.
Harjai, K. J. (1999). Ann. Intern. Med. 131, 376–386.
Clarkson, T. B. and Anthony, M. S. (1997). In: Estrogen and antiestrogens. Lindsay, R., Dempster, D. W., and Jordan, V. C. (eds.). Lippincott-Raven Publishers, Philadelphia, PA, pp. 89–118.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McBride, S.M., Flynn, F.W. & Ren, J. Cardiovascular alteration and treatment of hypertension. Endocr 28, 199–207 (2005). https://doi.org/10.1385/ENDO:28:2:199
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:28:2:199